Diabetic foot in the news

Findings from the Explorer trial show that a sucrose octasulfate dressing improves wound closure of neuroischemic diabetic foot ulcers relative to a standard dressing.

Hyperbaric oxygen therapy does not significantly improve wound healing or reduce major amputation rates when added to usual care in patients with diabetes and ischemic lower extremity ulcers, Dutch study data show.

A composite algorithm including the calprotectin biomarker can help physicians decide whether a diabetic foot ulcer needs antibiotic therapy, say researchers.

Here we provide an overview of the seven Cochrane reviews published in June that covered topics relating to diabetes, including glycemic control for prevention of renal failure, phototherapy for foot ulcers, and anti-vascular endothelial growth factor treatment for diabetic macular edema.

The integrated results of the CANVAS and CANVAS-R studies show that canagliflozin reduces the risk for cardiovascular and renal events in patients with type 2 diabetes at high cardiovascular risk.

Study findings suggest that the current annual incidence of diabetic foot may be lower than previously reported in the 1990s, despite the prevalence of diabetes nearly doubling in that time.